17-44172174-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080863.5(ASB16):c.430C>T(p.Arg144Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000936 in 1,612,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_080863.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASB16 | ENST00000293414.6 | c.430C>T | p.Arg144Cys | missense_variant | Exon 2 of 5 | 1 | NM_080863.5 | ENSP00000293414.1 | ||
ASB16 | ENST00000589618.1 | n.430C>T | non_coding_transcript_exon_variant | Exon 2 of 5 | 1 | ENSP00000466033.1 | ||||
ASB16 | ENST00000591700.1 | c.178C>T | p.Arg60Cys | missense_variant | Exon 3 of 3 | 4 | ENSP00000466349.1 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152152Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000172 AC: 43AN: 250032Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135408
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1460244Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 726528
GnomAD4 genome AF: 0.000558 AC: 85AN: 152270Hom.: 0 Cov.: 30 AF XY: 0.000363 AC XY: 27AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.430C>T (p.R144C) alteration is located in exon 2 (coding exon 2) of the ASB16 gene. This alteration results from a C to T substitution at nucleotide position 430, causing the arginine (R) at amino acid position 144 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at